Your browser doesn't support javascript.
loading
Cardiovascular and metabolic determinants of quality of life in patients with cancer.
Evertz, Ruben; Gödde, Katharina; Diehl, Christine; Valentova, Miroslava; Garfias-Veitl, Tania; Braulke, Friederike; Wulf, Gerald G; Overbeck, Tobias R; Bleckmann, Annalen; König, Alexander O; Weinländer, Pia; Potthoff, Sophia; Hadzibegovic, Sara; Lena, Alessia; Keller, Ulrich; Landmesser, Ulf; Schuster, Andreas; Anker, Markus S; Hasenfuß, Gerd; von Haehling, Stephan.
Afiliación
  • Evertz R; Department of Cardiology and Pneumology, University of Göttingen Medical Center (UMG), Göttingen, Germany.
  • Gödde K; German Center for Cardiovascular Research (DZHK), partner site Göttingen, 37075, Göttingen, Germany.
  • Diehl C; Department of Cardiology and Pneumology, University of Göttingen Medical Center (UMG), Göttingen, Germany.
  • Valentova M; Department of Cardiology and Pneumology, University of Göttingen Medical Center (UMG), Göttingen, Germany.
  • Garfias-Veitl T; Department of Paediatrics, University of Göttingen Medical Center (UMG), Göttingen, Germany.
  • Braulke F; Department of Cardiology and Pneumology, University of Göttingen Medical Center (UMG), Göttingen, Germany.
  • Wulf GG; German Center for Cardiovascular Research (DZHK), partner site Göttingen, 37075, Göttingen, Germany.
  • Overbeck TR; Department of Cardiology and Pneumology, University of Göttingen Medical Center (UMG), Göttingen, Germany.
  • Bleckmann A; German Center for Cardiovascular Research (DZHK), partner site Göttingen, 37075, Göttingen, Germany.
  • König AO; Department of Haematology and Medical Oncology, University of Göttingen Medical Center (UMG), Göttingen, Germany.
  • Weinländer P; Comprehensive Cancer Center G-CCC, University of Göttingen Medical Center (UMG), Göttingen, Germany.
  • Potthoff S; Department of Haematology and Medical Oncology, University of Göttingen Medical Center (UMG), Göttingen, Germany.
  • Hadzibegovic S; Department of Haematology and Medical Oncology, University of Göttingen Medical Center (UMG), Göttingen, Germany.
  • Lena A; Department of Haematology and Medical Oncology, University of Göttingen Medical Center (UMG), Göttingen, Germany.
  • Keller U; Department of Medicine, Hematology, Oncology, and Pneumology, University Hospital Münster, Münster, Germany.
  • Landmesser U; West German Cancer Center, University Hospital Münster, Münster, Germany.
  • Schuster A; Department of Gastroenterology, University of Göttingen Medical Center (UMG), Göttingen, Germany.
  • Anker MS; Department of Cardiology, Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin (CBF), Berlin, Germany.
  • Hasenfuß G; German Center for Cardiovascular Research (DZHK), partner site Berlin, Berlin, Germany.
  • von Haehling S; Division of Cardiology and Metabolism, Department of Cardiology (CVK), Charité University Medicine Berlin, Berlin, Germany.
ESC Heart Fail ; 10(1): 167-176, 2023 Feb.
Article en En | MEDLINE | ID: mdl-36178215
ABSTRACT

AIMS:

Maintaining quality of life (QoL) in patients with cancer has gathered significant interest, but little is known about its major determinants. We sought to identify determinants of QoL in patients undergoing cancer treatment as well as in treatment-naïve patients about to commence such therapy. METHODS AND

RESULTS:

QoL was assessed in 283 patients with cancer using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 questionnaire. All patients underwent a battery of tests including physical examination, resting electrocardiogram, hand grip strength, and biochemistry assessment. Using multivariable logistic regression, we found that age [odds ratio (OR) 0.954, 95% confidence interval (CI) 0.916-0.994], resting heart rate (OR 1.036, 95% CI 1.004-1.068), hand grip strength (OR 0.932, 95% CI 0.878-0.990), and the presence of cachexia (OR 4.334, 95% CI 1.767-10.631) and dyspnoea (OR 3.725, 95% CI 1.540-9.010; all P < 0.05) remained independently predictive of reduced QoL.

CONCLUSIONS:

Therefore, it may be reasonable to address circumstances that are affecting muscle mass, body weight, and heart rate to maintaining QoL; however, prospective studies to test these endpoints are required.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Calidad de Vida / Neoplasias Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: ESC Heart Fail Año: 2023 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Calidad de Vida / Neoplasias Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: ESC Heart Fail Año: 2023 Tipo del documento: Article País de afiliación: Alemania